华盛顿州妊娠期SARS-CoV-2感染的疾病严重程度、妊娠结局及孕产妇死亡
该多中心回顾性队列研究纳入2020年3月至6月华盛顿州240例PCR确诊SARS-CoV-2感染的孕妇,发现1/11发展为重症或危重症,1/10因COVID-19住院,1/80死亡;孕妇COVID-19住院率是同龄成人的3.5倍,病死率是同龄成人的13.6倍;分娩时重症或危重症者早产率显著高于轻症者。
要点
- 孕妇COVID-19住院率10.0%,显著高于同龄成人的2.8%(RR 3.5,95%CI 2.3-5.3)。
- 孕妇COVID-19病死率是同龄成人的13.6倍(95%CI 2.7-43.6),绝对死亡率差1.2%。
- 分娩时重症或危重症者早产率45.4%,显著高于轻症的5.2%(P<.001)。
核心结论
- 孕妇COVID-19住院率和病死率显著高于同龄成人,且重症或危重症者早产风险显著增加。
研究设计与样本
- 多中心回顾性队列研究,纳入2020年3月1日至6月30日华盛顿州35个中心240例PCR确诊SARS-CoV-2感染的孕妇,覆盖全州61%的年分娩量。
主要发现
- 240例孕妇中1/11发展为重症或危重症,1/10因COVID-19住院,1/80死亡。
- COVID-19相关住院率10.0%,同龄成人为2.8%(RR 3.5,95%CI 2.3-5.3)。
- 因呼吸问题住院的孕妇更可能合并哮喘、高血压、2型糖尿病、自身免疫病及III级肥胖等基础疾病。
- 3例孕产妇死亡归因于COVID-19(1.3%),孕产妇死亡率为1250/100000妊娠(95%CI 257-3653)。
- 孕妇COVID-19病死率是同龄成人的13.6倍(95%CI 2.7-43.6),绝对死亡率差1.2%(95%CI -0.3至2.6)。
临床怎么用
- 应重视孕妇COVID-19的住院和死亡风险,对合并基础疾病者加强监测。
- 分娩时重症或危重症COVID-19显著增加早产风险,需做好早产预案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence is accumulating that coronavirus disease 2019 increases the risk of hospitalization and mechanical ventilation in pregnant patients and for preterm delivery. However, the impact on maternal mortality and whether morbidity is differentially affected by disease severity at delivery and trimester of infection are unknown. OBJECTIVE: This study aimed to describe disease severity and outcomes of severe acute respiratory syndrome coronavirus 2 infections in pregnancy across the Washington State, including pregnancy complications and outcomes, hospitalization, and case fatality. STUDY DESIGN: Pregnant patients with a polymerase chain reaction-confirmed severe acute respiratory syndrome coronavirus 2 infection between March 1, 2020, and June 30, 2020, were identified in a multicenter retrospective cohort study from 35 sites in Washington State. Sites captured 61% of annual state deliveries. Case-fatality rates in pregnancy were compared with coronavirus disease 2019 fatality rates in similarly aged adults in Washington State using rate ratios and rate differences. Maternal and neonatal outcomes were compared by trimester of infection and disease severity at the time of delivery. RESULTS: The principal study findings were as follows: (1) among 240 pregnant patients in Washington State with severe acute respiratory syndrome coronavirus 2 infections, 1 in 11 developed severe or critical disease, 1 in 10 were hospitalized for coronavirus disease 2019, and 1 in 80 died; (2) the coronavirus disease 2019-associated hospitalization rate was 3.5-fold higher than in similarly aged adults in Washington State (10.0% vs 2.8%; rate ratio, 3.5; 95% confidence interval, 2.3-5.3); (3) pregnant patients hospitalized for a respiratory concern were more likely to have a comorbidity or underlying conditions including asthma, hypertension, type 2 diabetes mellitus, autoimmune disease, and class III obesity; (4) 3 maternal deaths (1.3%) were attributed to coronavirus disease 2019 for a maternal mortality rate of 1250 of 100,000 pregnancies (95% confidence interval, 257-3653); (5) the coronavirus disease 2019 case fatality in pregnancy was a significant 13.6-fold (95% confidence interval, 2.7-43.6) higher in pregnant patients than in similarly aged individuals in Washington State with an absolute difference in mortality rate of 1.2% (95% confidence interval, -0.3 to 2.6); and (6) preterm birth was significantly higher among women with severe or critical coronavirus disease 2019 at delivery than for women who had recovered from coronavirus disease 2019 (45.4% severe or critical coronavirus disease 2019 vs 5.2% mild coronavirus disease 2019; P<.001). CONCLUSION: Coronavirus disease 2019 hospitalization and case-fatality rates in pregnant patients were significantly higher than in similarly aged adults in Washington State. These data indicate that pregnant patients are at risk of severe or critical disease and mortality compared to nonpregnant adults, and also at risk for preterm birth.
引用
- Lokken EM, Huebner EM, Taylor GG, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021. PMID: 33515516. doi:10.1016/j.ajog.2020.12.1221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。